Inhibition of fibril formation and toxicity of a fragment of α-synuclein by an N-methylated peptide analogue

Neuroscience Letters

Volumn 359, Issue 1-2, 2004, Pages 89-93

  Bodles, Angela M ^a   El Agnaf, Omar M A ^b   Greer, Brett ^a   Guthrie, David J S ^a   Irvine, G Brent ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b LANCASTER UNIVERSITY   (United Kingdom)

Author keywords

synuclein; Amyloid; Cytotoxicity; Dementia with Lewy bodies; MTT; N Methylated peptide; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN; ALPHA SYNUCLEIN[68-78]; AMYLOID; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

AMYLOIDOSIS; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; ELECTRON MICROSCOPY; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METHYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN SYNTHESIS; RAT;

ALPHA-SYNUCLEIN; AMYLOID BETA-PROTEIN; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; NERVE TISSUE PROTEINS; PC12 CELLS; PEPTIDE FRAGMENTS; RATS; SENILE PLAQUES; SYNUCLEINS;

EID: 1842608890     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2003.12.077     Document Type: Article

References (15)

1. Bodles A.M., Guthrie D.J.S., Greer B., Irvine G.B. Identification of the region of non-Aβ component (NAC) of Alzheimer's disease amyloid responsible for its aggregation and toxicity. J. Neurochem. 78:2001;384-395.
2. Bodles A.M., Guthrie D.J.S., Harriott P., Campbell P., Irvine G.B. Toxicity of non-Aβ component of Alzheimer' s disease amyloid, and N-terminal fragments thereof correlates to formation of β-sheet structure and fibrils. Eur. J. Biochem. 267:2000;2186-2194.
3. El-Agnaf O.M.A., Bodles A.M., Guthrie D.J.S., Harriott P., Irvine G.B. The N-terminal region of non-Aβ component of Alzheimer' s disease amyloid is responsible for its tendency to assume β-sheet and aggregate to form fibrils. Eur. J. Biochem. 258:1998;157-163.
4. El-Agnaf O.M.A., Jakes R., Curran M.D., Wallace A. Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of α-synuclein protein implicated in Parkinson's disease. FEBS Lett. 440:1998;67-70.
5. Findeis M.A. Approaches to discovery and characterization of inhibitors of amyloid β-peptide polymerisation. Biochim. Biophys. Acta. 1502:2000;76-84.
6. Gordon D.J., Sciarretta K.L., Meredith S.C. Inhibition of β-amyloid (40) fibrillogenesis and disassembly of β-amyloid (40) fibrils by short β-amyloid congeners containing N-methyl amino acids at alternate residues. Biochemistry. 40:2001;8237-8245.
7. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 297:2002;353-356.
8. Hughes E., Burke R.M., Doig A.J. Inhibition of toxicity in the β-amyloid peptide fragment β3-(25-35) using N-methylated derivatives. J. Biol. Chem. 275:2000;25109-25115.
9. Kapurniotu A., Sehmauder A., Tenidis K. Structure-based design and study of non-amyloidogenic, double N-methylated IAPP amyloid core sequences as inhibitors of IAPP amyloid formation and cytotoxicity. J. Mol. Biol. 315:2002;339-350.
10. Kayed R., Head F., Thompson J.L., McIntire T.M., Milton S.C., Cotman C.W., Glabe C.G. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science. 300:2003;486-489.
11. Kruger R., Kuhn W., Muller T., Woitalla D., Graeber M., Kosel S., Przuntek H., Epplen J.T., Schols L., Riess O. Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease. Nat. Genet. 18:1998;106-108.
12. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., Di Iorio G., Golbe L.I., Nussbaum R.L. Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science. 276:1997;2045-2047.
13. Rajarathnam K., Sykes B.D., Kay C.M., Dewald B., Geiser T., Baggiolini M., Clark-Lewis I. Neutrophil activation by monomeric interleukin-B. Science. 264:1994;90-92.
14. Rijkers D.T.S., Hoppener J.W.M., Posthuma G., Lips C.J.M., Liskamp R.M.J. Inhibition of amyloid fibril formation of human amylin by N-alkylated amino acid and α-hydroxy acid residue containing peptides. Chem. Eur. J. 8:2002;4285-4291.
15. Spillantini M.G., Schmidt M.N., Lee V.M.Y., Trojanowski J.Q., Jakes R., Goedert M. α-synuclein in Lewy bodies. Nature. 388:1997;839-840.